Sentry Investment Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-457
Closed -$112K 546
2022
Q3
$112K Buy
457
+163
+55% +$44K 0.05% 342
2022
Q2
$73K Sell
294
-57
-16% -$15.4K 0.03% 433
2022
Q1
$116K Sell
351
-145
-29% -$44.6K 0.04% 412
2021
Q4
$178K Buy
496
+105
+27% +$35.5K 0.05% 348
2021
Q3
$127K Sell
391
-57
-13% -$19.3K 0.04% 403
2021
Q2
$140K Hold
448
0.04% 385
2021
Q1
$143K Sell
448
-2,140
-83% -$685K 0.04% 384
2020
Q4
$839K Hold
2,588
0.04% 343
2020
Q3
$717K Hold
2,588
0.04% 328
2020
Q2
$625K Buy
2,588
+1,662
+179% +$334K 0.04% 375
2020
Q1
$134K Sell
926
-1,649
-64% -$274K 0.01% 378
2019
Q4
$439K Hold
2,575
0.03% 406
2019
Q3
$458K Buy
2,575
+127
+5% +$27.5K 0.03% 388
2019
Q2
$638K Hold
2,448
0.04% 372
2019
Q1
$699K Sell
2,448
-217
-8% -$72.1K 0.05% 350
2018
Q4
$866K Sell
2,665
-70
-3% -$24.3K 0.06% 288
2018
Q3
$1.23M Hold
2,735
0.07% 260
2018
Q2
$1.12M Buy
+2,735
New +$991K 0.07% 275
2014
Q3
Sell
-30,042
Closed -$755K 538
2014
Q2
$755K Buy
+30,042
New +$699K 0.04% 329

Other funds holding ABMD

Sentry Investment Management's ABMD Position: Q4 2022 in Review

Sentry Investment Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 457 shares — an estimated $112K sold.

Sentry Investment Management first reported a position in ABMD in Q2 2014 and held it in 19 quarters. The position peaked at $1.23M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Sentry Investment Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Sentry Investment Management sold 457 Abiomed Inc shares in Q4 2022, an estimated $112K.
  • Sentry Investment Management first reported a position in Abiomed Inc in Q2 2014 and held it in 19 quarters.
  • Sentry Investment Management's Abiomed Inc position peaked at $1.23M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Sentry Investment Management's 13F filing for Q4 2022, filed 8 Feb 2023.